Stock Markets November 12, 2026 10:58 AM

Corteva trims full-year profit outlook as Brazil weakness drags crop protection sales

Shares plunge after company narrows adjusted profit guidance and flags softer-than-expected conditions in Brazil

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
CTVA

Corteva lowered its full-year adjusted profit forecast dramatically and cited persistent weakness in Brazilian crop protection demand. The company now expects adjusted profit of $0.76 to $0.80 per share, down from an earlier $3.60 to $3.80 range, and said market conditions in Brazil have been significantly softer than anticipated. Shares fell sharply on the news.

Corteva trims full-year profit outlook as Brazil weakness drags crop protection sales
CTVA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Corteva lowered full-year adjusted profit guidance to $0.76 - $0.80 per share from $3.60 - $3.80.
  • Shares fell 22.8% to $9.36, reaching a one-year low following the guidance cut.
  • Brazilic crop protection market softness - driven by farmer liquidity constraints, higher financing costs, just-in-time purchasing and pricing pressure - was cited as the main factor.

Nov 12 - Corteva shares fell to a one-year low after the US agrichemicals firm sharply reduced its full-year adjusted profit guidance, pointing to sustained softness in Brazil as the primary driver of the downgrade.

The company now projects adjusted earnings of $0.76 to $0.80 per share for the year, a substantial reduction from its prior forecast of $3.60 to $3.80 per share. The stock tumbled 22.8% to $9.36, marking what the company said was among the largest one-day percentage declines on record for the shares.

Corteva, which produces crop protection products including herbicides and fungicides, said the crop protection market has become more challenging, with Brazil singled out as an area of particular weakness.

Management attributed the softer-than-expected performance in Brazil to a combination of factors: farmer liquidity constraints, higher financing costs, a shift toward just-in-time purchasing and mounting pricing pressure. Together, these elements produced a significantly weaker market in Brazil than Corteva had anticipated.

Earlier this year, Corteva completed the separation of its seed and genetics operations into a separate publicly traded entity named Vylor. Since the spinoff, analysts flagged the potential for greater volatility in Corteva's results owing to the cyclicality inherent in the crop protection business.

Commenting on the company's first standalone earnings report, Oppenheimer analyst Kristen Owen said Corteva "stumbled out of the gate." Morningstar analyst Seth Goldstein added that following the spinoff, he expects Corteva's results to be more volatile due to the cyclical nature of crop protection.

Looking further ahead, Corteva provided a range for adjusted operating earnings before interest, taxes, depreciation and amortization for 2026, forecasting EBITDA of $1.1 billion to $1.125 billion. By contrast, analysts on average estimate EBITDA of $1.82 billion and adjusted profit of $1.63 per share for the year, according to data compiled by LSEG.


Market impact and context

The abrupt reduction in guidance and the steep share-price reaction underscore the sensitivity of crop protection revenues to regional market dynamics. Brazil's current combination of liquidity shortages among farmers and tighter financing conditions has translated into delayed or reduced purchasing of crop protection inputs, and rising pricing pressure has further weighed on near-term sales.

Investors and market participants will likely watch subsequent quarterly updates for signs that Brazilian demand is stabilizing and for any indications of margin recovery as pricing and purchasing patterns evolve.


Summary

Corteva drastically cut its annual adjusted profit outlook after reporting significant weakness in Brazil's crop protection market. The company now forecasts $0.76 to $0.80 per share for the year, and expects 2026 adjusted EBITDA between $1.1 billion and $1.125 billion. Shares plunged 22.8% to $9.36 on the news.

Risks

  • Continued weakness in Brazil could keep pressure on Corteva's revenue and margins - impacting the agrichemicals sector.
  • Higher financing costs and constrained farmer liquidity may prolong subdued purchasing patterns for crop protection products - affecting agricultural supply chains and related markets.
  • Greater volatility in Corteva's results following the seed and genetics spinoff could increase earnings uncertainty for investors in crop protection and chemicals.

More from Stock Markets

Union Pacific’s Fuel Surcharges Drive Quarterly Profit Gain While Rival BNSF Trails Nov 12, 2026 Madrid Stocks Close Lower; IBEX 35 Drops 0.31% as Financials and Telecoms Weigh Nov 12, 2026 Lisbon Market Nudges Higher as PSI Climbs to One-Month Peak Nov 12, 2026 AEX Ends Lower as Technology, Materials and Financials Drag Amsterdam Market Nov 12, 2026 DAX Hits Record High as German Market Moves Mixed; Sectors Split Between Gains and Losses Nov 12, 2026